Japan RA Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

STUDY VISITS

PATIENTS

RHEUMATOLOGISTS

Participating Sites

CorEvitas has clinical sites across Japan and we are always interested in expanding the registry for qualified sites.

Outcome measures in the CorEvitas Japan RA Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Calculated Outcomes

Patient Reported Outcomes

Euro-QoL Group EQ-5D-5L
Japanese version of the Health Assessment Questionnaire (J-HAQ)
Patient Global Assessment
Pain Visual Analogue Scale
Morning Stiffness Visual Analogue Scale
Fatigue Visual Analogue Scale
Work Productivity and Activity Impairment (WPAI)
Healthcare resource utilization

Registry Scientific Advisors

Hisashi Yamanaka, MD, PhD, Chair

Director, Sanno Medical Center | Professor of Rheumatology, International University of Health and Welfare Graduate School of Medicine

Mitsumasa Kishimoto, MD, PhD, FACP, FACR

Associate Professor, Kyorin University School of Medicine

Yoshiya Tanaka, MD, PhD

Consultant rheumatologist and Chairman, First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan | Dean, Graduate School of Medical Science, University of Occupational and Environmental Health, Japan | Chair of International Affairs, Co-Chair of Scientific Committee, APLAR | President, Japanese Society of Clinical Immunology

Subscribe to our newsletter